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Limited data exist regarding the prevalence of substance use disorders or utilization of mental health care during the COVID-19 pandemic. Our study aims to specifically identify trends
in the utilization of behavioral health units (BHU) in those with substance use disorders
(SUD).
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Patient electronic health records (EHR) were analyzed from fourteen hospitals principally located in the US mid-Atlantic region. To compare SUD admissions before and after COVID-19
quarantine time periods, patient data from BHUs were collected from two time-periods:
February 1st, 2019 to May 31st, 2019, and February 1st, 2020 to May 31st, 2020.

Results

The number of SUD admissions to BHUs did not change from 2019 to 2020 but there was a
statistically significant difference in the proportion of SUD patients admitted to BHUs (χ2 =
83.47, p < .001, V = 0.06). We also detected a significant difference in the proportion of SUD
severity between 2019 and 2020 with a small but significant overall decrease in the proportion of moderate/severe cases (χ2 = 5.70, p < .001, V = 0.05) in SUD patients.

Conclusion

Our data suggest that even during the times of a global pandemic when there is a decline
in health care utilization in other settings, the need for inpatient substance use treatment
should not be expected to decrease and increased use of telemedicine may be beneficial for
this vulnerable population.
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Background

Substance use disorders (SUD) are a growing
concern nationwide, with a 3-fold increase in
SUD-related deaths since the 1980s and with
total deaths from substance use exceeding
those due to motor vehicle crashes and gun
violence.1 Between 2002 and 2015, the national substance use disorder-related death rate
increased from 16.0 to 27.5 per 100,000.
Researchers have found that patients with
substance use disorders, in particular alcohol
use or substance use with comorbid psychiatric

disorders, have a higher health care utilization
rate,2 and that SUD was associated with a 30%
higher rate of specialty medical care services.
Yet limited data exist regarding the prevalence
of SUDs and the utilization of mental health
care during times of national emergency such
as the COVID-19 pandemic. Some studies have
suggested trends in mental health care needs
by citing data on the mental health impact in
China during previous outbreaks such as MERS
and SARS.3,4 These studies were focused specifically on the Chinese population and healthcare system, and provide limited insight into
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the impact of the COVID-19 pandemic within
the United States population and healthcare
system and specifically individuals with SUDs.
Some studies have examined health care
utilization world- and nationwide during the
pandemic,5-7 suggesting a decrease in utilization
of non-coronavirus-related medical services.
Despite this finding of decreased health care
utilization, editorials have been published suspecting a greater potential impact of COVID-19
on SUDs.8,9 Dr. Sederer refers to the conditions of the pandemic as “triple trouble” of a
pandemic, indicating that unemployment and
diminished personal and community supports
could lead to increased substance use.9 For
example, outpatient mental health services
including substance use services experienced a
reduction in outpatient visits and were required
to reduce services during the COVID-19 pandemic.10,11 However, no studies available have
demonstrated a trend in mental health care
utilization, specifically for SUDs during the
COVID-19 pandemic, and initial data from the
United States have been limited to literature
reviews.12
Our study aims to specifically identify trends in
the utilization of inpatient BHUs in those with
SUDs during the first stages of the COVID-19
pandemic compared to utilization the previous
year prior to the pandemic.

Methods

Study Population and Data Collection

Patient electronic health records (EHR) were
analyzed from fourteen hospitals principally

located in the US mid-Atlantic region. An HCA
Healthcare database analyst obtained the data,
which was delivered to the research team. To
compare SUD admissions before and after
COVID-19 quarantine time periods, patient
data from BHUs were collected from two
time-periods: February 1st, 2019 to May 31st,
2019, and February 1st, 2020 to May 31st, 2020.
A total of 26,858 patients admitted to BHUs
were identified.
In order to be included for further analyses,
patients (of the 26,858) had to have a SUD
in their top three diagnoses. Of the 26,858
patients admitted to BHUs during the two
time-periods, 2,391 patients met this criterion
(1,206 in 2019 and 1,185 in 2020). Demographics,
encounter and specific diagnoses data were
only made available for patients with SUDs. No
additional inclusion/exclusion criteria were applied. This study was deemed exempt from IRB
oversight by the US Office for Research Protections rule 45 CFR 46.104(d)(4) or “Common
Rule”.13 All data were stored on a password-protected virtual desktop instance. Before receiving the data for analyses by the research
team, the patients’ identifying information
was removed in accordance with “Safe Harbor”
standards,14 and an ID number was assigned.

Data Analyses

A chi-square test was conducted to compare
the proportion of SUD admissions during the
two time-periods. Additionally, of those with
SUDs, the proportion of mild versus moderate/severe designations were compared.
Descriptive statistics were also calculated for

Table 1. Demographic descriptive statistics and group comparisons.
Before
After
Mean(sd)
Age (years)

t / χ2

Cohen’s d /
Cramer’s V

40.7 (14.1)

39.8 (13.7)

132.33***

-0.07

Race (% Caucasian)

78.4%

76.5%

14.71*

0.13

Sex (% female)

38.7%

40.3%

0.52

0.02

5.16 (4.31)

5.56 (4.28)

42.44***

0.09

Length of Stay (days)
* p < .05, ** p < .01, *** p < .001

“Before” refers to February 2019-May 2019 time period and “After” refers to February 2020-May 2020 time
period.
Note: t-tests and Cohen’s d values are reported for continuous variables and χ2 and Cramer’s V values are
reported for categorical variables.
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Table 2. BHU admissions in 2019 and 2020 and proportion of SUD compared to total admission.
Before
After
Total
Δ
No SUD

14,695

9,763

24,485

4,932

SUD

1,206

1,185

2,391

21

Total Year

15,901

10,948

8%

11%*

Proportion SUD/Total
*χ2 = 83.47, p < .001, V = 0.06

“Before” refers to February 2019-May 2019 time period and “After” refers to February 2020-May 2020 time
period.

demographic information and appropriate
tests, including calculating effect sizes, were
conducted to investigate differences in demographics. Logistic regression analyses were
also conducted to further evaluate the role of
patient demographics in differentiating admission time and SUD severity and allowed for the
inclusion of multiple variables (as compared to
univariate tests). All analyses were conducted
in the R Statistical Environment.15

Results

Demographics

Demographics descriptive statistics and group
comparisons are reported in Table 1. Statistically significant differences in age, distribution
of race and hospital length of stay were found
between time periods; however, further examination of the effect sizes indicates that while
statistically different, the differences were
not “practically significant” and were likely the
result of the large sample size.

SUD Admissions

A 4,962 (31%) decrease in patients admitted
to BHUs from 2019 (n = 15,910) to 2020 (n =
10,948) was observed. A statistically significant
difference in the proportion of SUD patients

treated at BHUs during 2019 and 2020 (Table 2)
was detected (χ2 = 83.47, p < .001, V = 0.06) revealing increase in proportion of SUD patients
(from 8% to 11%). Importantly, the increase in
the proportion of SUD patients in 2020 was
due to the overall reduction in BHU patients,
not a change in the gross number of SUD patients (1,206 in 2019 to 1,185 in 2020).
In order to access the ability of different demographic variables to predict time of admission,
a logic regression was conducted to predict the
odds of admission time period membership using patient demographics (sex, race, insurance
type, length of stay and SUD severity). Only
SUD severity significantly predicted admission
time period (β = -0.28, p < .05, odds = 0.76)
indicating that there was a 24% decrease in the
odds of a patient with moderate/severe SUD
being admitted during the second time period.

SUD Severity

We also detected a significant difference in
the proportion of SUD severity between 2019
and 2020 (Table 3) with a small increase in the
number of mild cases and a small decrease in
the number of moderate/severe cases (χ2 =
5.70, p < .001, V = 0.05) in SUD patients. There

Table 3. Proportion of mild and moderate/severe cases 2019 and 2020.
Before

After

Total

Δ

Mild

904

932

1799

-28

Moderate/Severe

302

253

537

49

Total Year

1206

1185

Proportion Mild/Total

75%

79%*

*χ = 5.70, p < .001, V = 0.05
2

“Before” refers to February 2019-May 2019 time period and “After” refers to February 2020-May 2020 time
period.
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was not a statistically significant change in the
proportion of SUD types (e.g., opioids, alcohol,
etc.) between the two time-periods.
Finally, we report the results of a logistic regression model to predict the odds of having
mild or moderate/severe SUD using patient
demographics. Patients admitted before the
COVID-19 pandemic (β = -0.27, p < .05, odds =
0.76) and not insured by Medicaid (β = -0.33, p
< .05, odds = 0.71) had a 24% and 29% decrease
in the odds of having a moderate/severe SUD
diagnosis, respectively. There was no significant association between admission period and
any demographic variable, including sex, age or
insurance.

Discussion

Our results show an increase in the proportion of patients admitted with SUDs to BHUs
during the pandemic compared to the year
prior, before the start of the pandemic. This
change in proportion reflected a decrease in
total admissions with little change in SUD admission rates from 2020 compared to 2019. The
cause for these findings is not fully known at
this time and will require further studies.
Previous studies have seen an overall hesitancy to avoid medical care during the COVID-19
pandemic even amongst patients with heart
failure.5 This hesitancy was also seen in BHUs as
evidenced by the 31% decrease in total admissions compared to the year prior. Because the
number of inpatient admissions for substance
use did not decrease, this shows that the utilization of inpatient SUD treatment continued
during the pandemic. While there was a lower
medical care utilization in certain populations
and settings during the pandemic, our results
stress the importance of continuing to provide
sufficient resources and treatment for patients
with SUDs in the inpatient setting.
Our study was observational and cannot prove
the cause of this change in SUD proportion.
A possible explanation, however, is that isolation,16 unemployment and limited access to
community resources like Alcoholics Anonymous17 increased problematic substance use.
Research using animal models (e.g., rats and
rhesus monkeys) support the conclusion that
social isolation increases substance abuse.18,19
Furthermore, positive romantic relationships
and attending religious services, for example,
436

are two activities that appear to have protective effects against substance abuse, both of
which are limited by the pandemic.20 Our finding that there was a statistically significant increase in the number and the proportion of patients with mild SUDs compared to moderate/
severe SUDs, after controling for demographic
variables (see logistic regression results), may
support the conclusion that the current pandemic environment has increased problematic
substance use among individuals that previously did not meet SUD criteria. Because of these
“new” patients that developed SUDs during the
pandemic, total admissions did not decrease
despite general hesitancy to seek medical care.
However, these changes were relatively small
and may simply reflect the change in proportion of total SUD patients to total BHU from
2019 to 2020.
A second explanation is that there were no
differences in patients from the two time-periods. Some research suggests that individuals
with SUDs are more likely to engage in risky
health behaviors21 and impulsive decision-making,22 which may result in an insensitivity to the
risk of seeking medical attention. We did not
find meaningful differences (statistically different but clinically negligible) in demographic
variables and these demographic variables did
not predict admission time period. Given the
similarity in demographic variables, as well as
no change in proportion of different SUD diagnoses, it is possible a similar group of patients
was admitted during the pandemic as the year
prior. The increase in mild diagnoses and decrease in moderate/severe diagnoses could indicate that patients with previous SUD diagnoses seeking inpatient care as their only option
due to the unavailability of other personal and
community substance abuse treatments (e.g.,
AA) during the pandemic. Further research is
needed to identify the most plausible cause for
the change in SUD proportions.
One factor that could account for the change
in the proportion of BHU admissions is the
increased utilization of telemedicine during the
COVID-19 pandemic. Telemedicine has shown
to decrease alcohol consumption in a systematic review published earlier this year.23 There
has been an increase in the amount of telemedicine utilized for SUDs from 2016–2019 but
this increase has been slow, non-homogenous
and likely under-utilized.24 The CDC published
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recommendations to optimize the use of
telehealth during the COVID-19 pandemic.25
According to data collected by FAIR Health Inc.
for the southern region of the United States,
there has been a dramatic increase in telemedicine use during the pandemic especially for
mental health treatment.26 In February 2020,
telemedicine had seen a 212.42% increase in
percent of medical claim lines utilizing telehealth compared to February 2019 and mental health conditions accounted for 12.55% of
telehealth claim lines. By May 2020 there was a
3,434.64% increase in percent of medical claims
utilizing telehealth compared to May 2019 and
mental health conditions accounted for 32.49%
of telehealth claim lines. In the early months
of the pandemic, telehealth was not as available or highly utilized for patients with mental
health conditions. As outpatient clinics were
also closed, patients with SUD, whether new
or those with previous diagnoses, may have
presented to the inpatient BHUs as their only
option. However, it is possible that this increase
in telehealth use encapsulates depression and
anxiety diagnoses but not SUDs, accounting for
our findings.
Another advantage of telehealth services for
mild SUD is the potential reduction in health
care costs for the patient. We found that patients not insured by Medicaid (a federal-state
funded healthcare plan that typically covers
most medical costs) were less likely to be diagnosed with a moderate/severe SUD. Telehealth
may provide a more affordable treatment outlet for patients with mild SUD than more expensive inpatient care. Telemedicine utilization
should continue to increase for patients with
SUDs as it may be a useful tool to decrease
substance use as well as rate of admissions
to inpatient BHUs, and thus reduce possible
exposure to infected individuals and health care
costs, especially in those with mild SUDs.
In summary, our results suggest that even
during the times of a global pandemic, when
health care utilization in many settings declines, the need for inpatient substance use
treatment should not be expected to decrease
and necessary resources should continue to be
allocated. Availability and improvement of telehealth services could be considered to prevent
and treat the development or relapse of substance use that may have occurred during the

pandemic and decrease admissions to inpatient
BHUs,27 thus reducing risk of exposure and
health care costs.

Conflicts of Interest

The authors declare they have no conflicts of
interest.
Drs. McDonald and Zhang are employees of
LewisGale Medical Center, a hospital affiliated
with the journal’s publisher.
Dr. DeHart is an employee of HCA Healthcare
Physician Services Group, an organization
affiliated with the journal’s publisher.
This research was supported (in whole or in
part) by HCA Healthcare and/or an
HCA Healthcare affiliated entity. The views
expressed in this publication represent those of
the author(s) and do not necessarily represent
the official views of HCA Healthcare or any of
its affiliated entities.

Author Affiliations

1. LewisGale Medical Center, Salem, VA
2. HCA Healthcare Capital Division Director of
Research

References
1.

2.

3.

4.

5.

Snider JT, Duncan ME, Gore MR, et al. Association Between State Medicaid Eligibility
Thresholds and Deaths Due to Substance Use
Disorders. JAMA Netw Open. 2019;2(4):e193056.
Published 2019 Apr 5. https://doi.org/10.1001/
jamanetworkopen.2019.3056
de Weert-van Oene GH, Termorshuizen F, Buwalda VJA, Heerdink ER. Somatic health care
utilization by patients treated for substance use
disorders. Drug Alcohol Depend. 2017;178:277-284.
https://doi.org/10.1016/j.drugalcdep.2017.05.022
Wang C, Pan R, Wan X, et al. Immediate Psychological Responses and Associated Factors during
the Initial Stage of the 2019 Coronavirus Disease
(COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health.
2020;17(5):1729. Published 2020 Mar 6. https://
doi.org/10.3390/ijerph17051729
Xiang YT, Yang Y, Li W, et al. Timely mental
health care for the 2019 novel coronavirus
outbreak is urgently needed. Lancet Psychiatry.
2020;7(3):228-229. https://doi.org/10.1016/s22150366(20)30046-8
De Rosa S, Spaccarotella C, Basso C, et al.
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J.
2020;41(22):2083-2088. https://doi.org/10.1093/
eurheartj/ehaa409

437

HCA Healthcare Journal of Medicine

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.
16.

17.

438

Hall ME, Vaduganathan M, Khan MS, et al.
Reductions in Heart Failure Hospitalizations
During the COVID-19 Pandemic. J Card Fail.
2020;26(6):462-463. https://doi.org/10.1016/j.
cardfail.2020.05.005
Sen S, Karaca-Mandic P, Georgiou A. Association
of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States. JAMA. 2020;323(24):25222524. https://doi.org/10.1001/jama.2020.9176
NIDA. COVID-19: Potential Implications for Individuals with Substance Use Disorders. National
Institute on Drug Abuse website. https://www.
drugabuse.gov/about-nida/noras-blog/2020/04/
covid-19-potential-implications-individuals-substance-use-disorders. April 6, 2020 Accessed
June 29, 2020.
Sederer LI. What Past Disasters Tell Us
About COVID-19 and Substance Abuse. Medscape. https://www.medscape.com/viewarticle/930594. Published May 18, 2020. Accessed
June 25, 2020.
Samuels EA, Clark SA, Wunsch C, et al.
Innovation During COVID-19: Improving
Addiction Treatment Access. J Addict Med.
2020;14(4):e8-e9. https://doi.org/10.1097/
adm.0000000000000685
Mehrotra et al., “The Impact of the COVID-19
Pandemic on Outpatient Visits: A Rebound
Emerges,” To the Point (blog), Commonwealth
Fund, May 19, 2020. https://doi.org/10.26099/
ds9e-jm36
Lima CKT, Carvalho PMM, Lima IAAS, et al. The
emotional impact of Coronavirus 2019-nCoV
(new Coronavirus disease). Psychiatry Res.
2020;287:112915. https://doi.org/10.1016/j.psychres.2020.112915
HHS.gov. 45 CFR 46. US Department of Health
and Human Services. Accessed July 16, 2020.
https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html
HHS.gov. Guidance Regarding Methods for
De-identification of Protected Health Information in Accordance with the Health Insurance
Portability and Accountability Act (HIPAA) Privacy Rule. US Department of Health and Human
Services. Accessed July 7, 2020. https://www.
hhs.gov/hipaa/for-professionals/privacy/special-topics/de-identification/index.html.
R Core Team. R: A language and environment for
statistical computing. R Foundation for Statistical Computing. 2014. http://www.r-project.org/
Compton WM, Gfroerer J, Conway KP, Finger
MS. Unemployment and substance outcomes in
the United States 2002-2010. Drug Alcohol Depend. 2014;142:350-353. https://doi.org/10.1016/j.
drugalcdep.2014.06.012
Chou KL, Liang K, Sareen J. The association
between social isolation and DSM-IV mood,
anxiety, and substance use disorders: wave 2
of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry.

18.

19.

20.

21.

22.

23.

24.

25.

26.
27.

2011;72(11):1468-1476. https://doi.org/10.4088/
jcp.10m06019gry
Kulkosky PJ, Zellner DA, Hyson RL, et al. Ethanol
consumption of rats in individual, group, and
colonial housing conditions. Physiological Psychology. 1980;8:56–60. https://doi.org/10.3758/
BF03326448
Higley JD, Hasert MF, Suomi SJ, Linnoila M.
Nonhuman primate model of alcohol abuse: effects of early experience, personality, and stress
on alcohol consumption. Proc Natl Acad Sci U S
A. 1991;88(16):7261-7265. https://doi.org/10.1073/
pnas.88.16.7261
Day BF, Rosenthal GL. Social isolation proxy
variables and prescription opioid and benzodiazepine misuse among older adults in the U.S.:
A cross-sectional analysis of data from the National Survey on Drug Use and Health, 2015-2017.
Drug Alcohol Depend. 2019;204:107518. https://
doi.org/10.1016/j.drugalcdep.2019.06.020
Bickel WK, Athamneh LN, Basso JC, et al. Excessive discounting of delayed reinforcers as a
trans-disease process: Update on the state of
the science. Curr Opin Psychol. 2019;30:59-64.
https://doi.org/10.1016/j.copsyc.2019.01.005
Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use
disorders: review of findings from high-risk
research, problem gamblers and genetic association studies. Neurosci Biobehav Rev.
2008;32(4):777-810. https://doi.org/10.1016/j.
neubiorev.2007.11.003
Kruse CS, Lee K, Watson JB, Lobo LG, Stoppelmoor AG, Oyibo SE. Measures of Effectiveness,
Efficiency, and Quality of Telemedicine in the
Management of Alcohol Abuse, Addiction, and
Rehabilitation: Systematic Review. J Med Internet Res. 2020;22(1):e13252. Published 2020 Jan 31.
https://doi.org/10.2196/13252
Uscher-Pines L, Cantor J, Huskamp HA, Mehrotra A, Busch A, Barnett M. Adoption of
telemedicine services by substance abuse
treatment facilities in the U.S. J Subst Abuse
Treat. 2020;117:108060. https://doi.org/10.1016/j.
jsat.2020.108060
CDC.gov. Healthcare Facilities: Managing
Operations During the COVID-19 Pandemic.
Published June 28, 2020. Accessed July 20, 2020.
https://www.cdc.gov/coronavirus/2019-ncov/
hcp/guidance-hcf.html
Monthly telehealth regional tracker. FAIR Health.
Accessed September 7, 2020. https://www.fairhealth.org/states-by-the-numbers/telehealth.
Stephens JR, Liles EA, Dancel R, Gilchrist M,
Kirsch J, DeWalt DA. Who needs inpatient
detox? Development and implementation of a
hospitalist protocol for the evaluation of patients for alcohol detoxification. J Gen Intern
Med. 2014;29(4):587-593. https://doi.org/10.1007/
s11606-013-2751-3

